Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

How Has the Smoking Cessation Products Market Size Changed, over the years?

In recent years, the market size for smoking cessation products has observed considerable growth. Projected increase from $22.25 billion in 2024 to $24.13 billion in 2025, with a compound annual growth rate (CAGR) of 8.5%, is expected. The historic growth pattern is a result of an increased understanding of health hazards related to smoking, the escalating prevalence of respiratory diseases due to smoking, advocacy from government initiatives and public health campaigns for quitting, a heightened uptake of nicotine replacement therapies, and increased medical spending on diseases related to smoking.

How Much Will the Smoking Cessation Products Market Be Worth in 2029?

Strong expansion is expected in the market size of smoking cessation products over the next few years, with a forecasted growth to $32.98 billion in 2029, showcasing a compound annual growth rate (CAGR) of 8.1%. Factors causing this surge during the forecast period include an escalation in quitting attempts by smokers, an increase in elderly populations with high smoking prevalence, a regulatory landscape that promotes quitting endeavours, an upsurge in cancers related to tobacco usage, and an expansion in tobacco control tactics and taxation. The forecast period will also encounter key trends such as the presence of various product types, the utilization of nicotine replacement therapy, improved accessibility and availability of quitting aids, the incorporation of behavioral therapies into quitting products, and advancements in technology in product delivery mechanisms.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24708&type=smp

Which is the Largest Company in the Smoking Cessation Products Market?

Major companies operating in the smoking cessation products market are Pfizer Inc., Johnson & Johnson, Novartis AG, Imperial Brands PLC, GlaxoSmithKline (GSK), British American Tobacco PLC, Philip Morris International Inc., Haleon Group of Companies, Perrigo Company, Dr. Reddy’s Laboratories, Cipla Ltd., Fertin Pharma, Lucy, Euro-Pharm International Canada Inc., Alkalon A/S, Enorama Pharma AB, Niconovum AB, Sparsha Pharma International Pvt Ltd, The Harvard Drug Group, Revolymer.

What Are the Main Market Drivers in the Smoking Cessation Products Industry?

The anticipated increase in the prevalence of diseases related to smoking is expected to propel the smoking cessation products’ market growth in future years. Diseases linked to tobacco use, whether direct or indirect, have a significant impact on various organs and bodily functions. The sustained practice of tobacco usage results in smoking-related diseases increasing due to the prolonged introduction of harmful chemicals that deteriorate vital organs and elevate chronic disease risk over time. Consequently, this surge in smoking-related diseases boosts the demand for smoking cessation products, as heightened health consciousness and diagnostic disclosures drive more individuals to seek efficient measures to stop smoking and lower their risk of contracting severe illnesses. For example, a prediction by the American Cancer Society, a non-profit organization based in the U.S, in January 2025, suggests that there will be roughly 226,650 fresh cases of lung cancer in the year for the United States. Such new cases are anticipated to be split into approximately 110,680 male cases and 115,970 female cases. Deaths due to lung cancer are projected to be around 124,730, split between around 64,190 men and 60,540 women. Therefore, the increasing load of diseases due to smoking will likely accelerate the growth of the market for smoking cessation products.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=24708&type=smp

How Is the Smoking Cessation Products Market Segments Structured?

The smoking cessation products market covered in this report is segmented –

1) By Product Type: Nicotine Replacement Therapy, Prescription Drugs, Over-The-Counter Drugs, Electronic Cigarettes

2) By Formulation Type: Gums, Lozenges, Patches, Inhalers, Nasal Sprays

3) By Distribution Channel: Pharmacies, Online Retail, Supermarkets, Health Care Providers

4) By End-User: Adults, Teenagers, Pregnant Women

Subsegments:

1) By Nicotine Replacement Therapy: Gum, Patch, Lozenge, Inhaler, Nasal Spray

2) By Prescription Drugs: Varenicline, Bupropion, Nortriptyline, Clonidine

3) By Over-The-Counter Drugs: Nicotine Gum, Nicotine Lozenges, Herbal Lozenges, Non-nicotine Tablets

4) By Electronic Cigarettes: Disposable E-cigarettes, Rechargeable E-cigarettes, Modular E-cigarettes, Pod-Based E-cigarettes

What Strategic Trends Are Transforming the Smoking Cessation Products Market?

Primary businesses in the smoking cessation product industry, such as Rusan Pharma, are honing in on the development of de-addiction initiatives that build a supportive community network to bolster successful recovery and deter potential relapses. De-addiction campaigns are structured endeavors aiming to increase awareness, lend support to individuals wrestling with substance addiction, and encourage a shift towards healthier living habits. In April 2023, for example, Rusan Pharma – a pharmaceutical company based in India – kicked off a campaign advocating for tobacco de-addiction using their 2baconil brand, a nicotine patch deliverable 24/7. The #NoReasonIsGoodEnough campaign crafted by 2baconil underlines common justifications individuals employ to rationalize their smoking habits. The campaign highlights the effectiveness of 2baconil nicotine patches in mitigating both psychological and physiological nicotine dependencies. The brand provides its nicotine patches and gum formats to help users halt their smoking routines.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/smoking-cessation-products-global-market-report

Which Global Regions Offer the Highest Growth in the Smoking Cessation Products Market?

North America was the largest region in the smoking cessation products market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the smoking cessation products market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=24708

This Report Delivers Insight On:

1. How big is the smoking cessation products market, and how is it changing globally?

2. Who are the major companies in the smoking cessation products market, and how are they performing?

3. What are the key opportunities and risks in the smoking cessation products market right now?

4. Which products or customer segments are growing the most in the smoking cessation products market?

5. What factors are helping or slowing down the growth of the smoking cessation products market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model